{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T00:06:56Z","timestamp":1794355616147,"version":"4.9.0"},"reference-count":213,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T00:00:00Z","timestamp":1756252800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T00:00:00Z","timestamp":1756252800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetol Metab Syndr"],"DOI":"10.1186\/s13098-025-01930-2","type":"journal-article","created":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T02:46:11Z","timestamp":1756262771000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["A systematic review on type 3 diabetes: bridging the gap between metabolic dysfunction and Alzheimer\u2019s disease"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6051-2644","authenticated-orcid":false,"given":"Fereshteh","family":"Atabi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-3313-4930","authenticated-orcid":false,"given":"Mahdi","family":"Moassesfar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-1006-4452","authenticated-orcid":false,"given":"Tara","family":"Nakhaie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-4641-0208","authenticated-orcid":false,"given":"Mobina","family":"Bagherian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-6698-215X","authenticated-orcid":false,"given":"Niloufar","family":"Hosseinpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0627-6991","authenticated-orcid":false,"given":"Mehrdad","family":"Hashemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,27]]},"reference":[{"issue":"1","key":"1930_CR1","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13098-025-01582-2","volume":"17","author":"M Zhou","year":"2025","unstructured":"Zhou M, Shen Q, Li B. JAK inhibitors: a new choice for diabetes mellitus? Diabetol Metab Syndr. 2025;17(1):33.","journal-title":"Diabetol Metab Syndr"},{"issue":"1","key":"1930_CR2","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1186\/s13098-024-01518-2","volume":"16","author":"P Khashayar","year":"2024","unstructured":"Khashayar P, Rad FF, Tabatabaei-Malazy O, Golabchi SM, Khashayar P, Mohammadi M, et al. Hypoglycemic agents and bone health; an umbrella systematic review of the clinical trials\u2019 meta-analysis studies. Diabetol Metab Syndr. 2024;16(1):310.","journal-title":"Diabetol Metab Syndr"},{"key":"1930_CR3","doi-asserted-by":"crossref","unstructured":"Gr\u00fcnblatt E, Yde Ohki CM, Schmitt-B\u00f6hrer GA, Riederer P, Walitza S. Exploring the interplay of glucose metabolism, insulin resistance, and neurodegenerative pathologies: insights from streptozotocin and hypoglycaemic in vitro models. J Neural Transm. 2025.","DOI":"10.1007\/s00702-025-02891-6"},{"key":"1930_CR4","doi-asserted-by":"crossref","unstructured":"Kciuk M, Kruczkowska W, Ga\u0142\u0119ziewska J, Wanke K, Ka\u0142uzi\u0144ska-Ko\u0142at \u017b, Aleksandrowicz M et al. Alzheimer\u2019s Disease as Type 3 Diabetes: Understanding the Link and Implications. International Journal of Molecular Sciences. 2024;25(22).","DOI":"10.3390\/ijms252211955"},{"key":"1930_CR5","first-page":"333","volume-title":"Chapter 16 - Glucose, glycolysis, and neurodegenerative disorders","author":"P Coelho","year":"2024","unstructured":"Coelho P, Rego AC. In: Ferreira R, Oliveira PF, Nogueira-Ferreira R, editors. Chapter 16 - Glucose, glycolysis, and neurodegenerative disorders. Glycolysis: Academic; 2024. pp. 333\u201384."},{"issue":"1","key":"1930_CR6","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1007\/s44187-025-00422-6","volume":"5","author":"F Nurkolis","year":"2025","unstructured":"Nurkolis F, Harbuwono DS, Taslim NA, Soegondo S, Suastika K, Sparringa RA, et al. New insight on dietary strategies to increase insulin sensitivity and reduce diabetes prevalence: an expert perspective and recommendation. Discover Food. 2025;5(1):136.","journal-title":"Discover Food"},{"key":"1930_CR7","doi-asserted-by":"crossref","unstructured":"Ayoub S, Arabi M, Al-Najjar Y, Laswi I, Outeiro TF, Chaari A. Glycation in Alzheimer\u2019s disease and type 2 diabetes: the prospect of dual drug approaches for therapeutic interventions. Mol Neurobiol. 2025.","DOI":"10.1007\/s12035-025-05051-9"},{"key":"1930_CR8","doi-asserted-by":"crossref","unstructured":"Khalid M, Petroianu G, Adem A. Advanced glycation end products and diabetes mellitus: mechanisms and perspectives. Biomolecules. 2022;12(4).","DOI":"10.3390\/biom12040542"},{"key":"1930_CR9","doi-asserted-by":"crossref","unstructured":"Gonz\u00e1lez P, Lozano P, Ros G, Solano F. Hyperglycemia and oxidative stress: an integral, updated and critical overview of their metabolic interconnections. Int J Mol Sci. 2023;24(11).","DOI":"10.3390\/ijms24119352"},{"issue":"1","key":"1930_CR10","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s13098-024-01346-4","volume":"16","author":"F Cao","year":"2024","unstructured":"Cao F, Yang F, Li J, Guo W, Zhang C, Gao F, et al. The relationship between diabetes and the dementia risk: a meta-analysis. Diabetol Metab Syndr. 2024;16(1):101.","journal-title":"Diabetol Metab Syndr"},{"issue":"2","key":"1930_CR11","first-page":"e22193","volume":"14","author":"A Malik","year":"2022","unstructured":"Malik A, Ahmed M, Mansoor S, Ambreen S, Usman B, Shehryar M. Cognitive impairment in type 2 diabetes mellitus. Cureus. 2022;14(2):e22193.","journal-title":"Cureus"},{"issue":"7","key":"1930_CR12","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1016\/j.jdiacomp.2016.06.005","volume":"30","author":"RM Salinas","year":"2016","unstructured":"Salinas RM, Hiriart M, Acosta I, Sosa AL, Prince MJ. Type 2 diabetes mellitus as a risk factor for dementia in a Mexican population. J Diabetes Complications. 2016;30(7):1234\u20139.","journal-title":"J Diabetes Complications"},{"issue":"1","key":"1930_CR13","doi-asserted-by":"publisher","first-page":"100188","DOI":"10.1016\/j.appr.2023.100188","volume":"6","author":"S Mechref","year":"2024","unstructured":"Mechref S, Hatem G, Nehme H, Mhanna R, Meouch S, Rachidi S. Factors affecting cognitive decline among patients with diabetes: A cross-sectional study in Lebanon. Atenci\u00f3n Primaria Pr\u00e1ctica. 2024;6(1):100188.","journal-title":"Atenci\u00f3n Primaria Pr\u00e1ctica"},{"key":"1930_CR14","doi-asserted-by":"publisher","first-page":"110976","DOI":"10.1016\/j.diabres.2023.110976","volume":"205","author":"Y Zheng","year":"2023","unstructured":"Zheng Y, Ma Q, Qi X, Zhu Z, Wu B. Prevalence and incidence of mild cognitive impairment in adults with diabetes in the united States. Diabetes Res Clin Pract. 2023;205:110976.","journal-title":"Diabetes Res Clin Pract"},{"issue":"9","key":"1930_CR15","doi-asserted-by":"publisher","first-page":"2600","DOI":"10.2337\/dc12-2158","volume":"36","author":"ER Mayeda","year":"2013","unstructured":"Mayeda ER, Haan MN, Kanaya AM, Yaffe K, Neuhaus J. Type 2 diabetes and 10-year risk of dementia and cognitive impairment among older Mexican Americans. Diabetes Care. 2013;36(9):2600\u20136.","journal-title":"Diabetes Care"},{"issue":"7","key":"1930_CR16","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1016\/j.jdiacomp.2016.06.005","volume":"30","author":"RM Salinas","year":"2016","unstructured":"Salinas RM, Hiriart M, Acosta I, Sosa AL, Prince MJ. Type 2 diabetes mellitus as a risk factor for dementia in a Mexican population. J Diabetes Complicat. 2016;30(7):1234\u20139.","journal-title":"J Diabetes Complicat"},{"key":"1930_CR17","doi-asserted-by":"crossref","unstructured":"Bozanic A, Toro P, Bello-Lepe S, Hurtado-Oliva J, Beyle C, Vald\u00e9s C et al. Cognitive impairment with type 2 diabetes mellitus among community-dwelling older adults in chile: prevalence, risk factors and cognitive characteristics. Front Hum Neurosci. 2023;16.","DOI":"10.3389\/fnhum.2022.1070611"},{"key":"1930_CR18","doi-asserted-by":"crossref","unstructured":"Shamsudeen RP, Sridhar M, Singla S, Gupta R, Mittal V. N, Prevalence and factors associated with cognitive impairment among persons with type 2 diabetes mellitus: a cross-sectional study in medical college hospitals of South India. Clin Epidemiol Global Health. 2024;31:101887.","DOI":"10.1016\/j.cegh.2024.101887"},{"issue":"1","key":"1930_CR19","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s40520-024-02806-7","volume":"36","author":"V Boccardi","year":"2024","unstructured":"Boccardi V, Travaglini EG, Sciacca E, Mancinetti F, Murasecco I, Guazzarini AG, et al. Dysglycemia, gender, and cognitive performance in older persons living with mild cognitive impairment: findings from a cross-sectional, population-based study. Aging Clin Exp Res. 2024;36(1):145.","journal-title":"Aging Clin Exp Res"},{"issue":"9","key":"1930_CR20","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1016\/j.jalz.2018.05.015","volume":"14","author":"MA Espeland","year":"2018","unstructured":"Espeland MA, Carmichael O, Yasar S, Hugenschmidt C, Hazzard W, Hayden KM, et al. Sex-related differences in the prevalence of cognitive impairment among overweight and obese adults with type 2 diabetes. Alzheimers Dement. 2018;14(9):1184\u201392.","journal-title":"Alzheimers Dement"},{"issue":"7","key":"1930_CR21","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1007\/s00125-018-4547-9","volume":"61","author":"G Schernthaner","year":"2018","unstructured":"Schernthaner G, Schernthaner-Reiter MH. Diabetes in the older patient: heterogeneity requires individualisation of therapeutic strategies. Diabetologia. 2018;61(7):1503\u201316.","journal-title":"Diabetologia"},{"key":"1930_CR22","doi-asserted-by":"crossref","unstructured":"Harris K, Gong J, Shah M, Hajat S, Xu Y, Carcel C et al. Ethnic differences in risk factors for cognitive decline and dementia, in individuals with diabetes: Results from the advance trial. J Hypertens. 2023;41(Suppl 3).","DOI":"10.1097\/01.hjh.0000940508.73711.32"},{"issue":"1","key":"1930_CR23","doi-asserted-by":"publisher","first-page":"241","DOI":"10.3233\/JAD-220036","volume":"88","author":"SF Ang","year":"2022","unstructured":"Ang SF, Low S, Ng TP, Tan CSH, Ang K, Lim Z, et al. Ethnic-Specific type 2 diabetes risk factor PAX4 R192H is associated with Attention-Specific cognitive impairment in Chinese with type 2 diabetes. J Alzheimers Dis. 2022;88(1):241\u20139.","journal-title":"J Alzheimers Dis"},{"key":"1930_CR24","doi-asserted-by":"crossref","unstructured":"Pan J, Yao Q, Wang Y, Chang S, Li C, Wu Y et al. The role of PI3K signaling pathway in Alzheimer\u2019s disease. Front Aging Neurosci. 2024;16.","DOI":"10.3389\/fnagi.2024.1459025"},{"key":"1930_CR25","doi-asserted-by":"crossref","unstructured":"Albaik M, Sheikh Saleh D, Kauther D, Mohammed H, Alfarra S, Alghamdi A et al. Bridging the gap: glucose transporters, Alzheimer\u2019s, and future therapeutic prospects. Front Cell Dev Biology. 2024;12.","DOI":"10.3389\/fcell.2024.1344039"},{"issue":"8","key":"1930_CR26","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1080\/07853890.2016.1197416","volume":"48","author":"O Pivovarova","year":"2016","unstructured":"Pivovarova O, H\u00f6hn A, Grune T, Pfeiffer AFH, Rudovich N. Insulin-degrading enzyme: new therapeutic target for diabetes and Alzheimer\u2019s disease? Ann Med. 2016;48(8):614\u201324.","journal-title":"Ann Med"},{"key":"1930_CR27","doi-asserted-by":"publisher","first-page":"101500","DOI":"10.1016\/j.rechem.2024.101500","volume":"7","author":"N Jitendra Joshi","year":"2024","unstructured":"Jitendra Joshi N, Raja Sekhar Reddy A. Navigating the GSK-3\u03b2 inhibitors as versatile multi-target drug ligands in Alzheimer\u2019s disease intervention \u2013 A comprehensive review. Results Chem. 2024;7:101500.","journal-title":"Results Chem"},{"key":"1930_CR28","doi-asserted-by":"crossref","unstructured":"Dash UC, Bhol NK, Swain SK, Samal RR, Nayak PK, Raina V et al. Oxidative stress and inflammation in the pathogenesis of neurological disorders: mechanisms and implications. Acta Pharm Sinica B. 2024;15(1).","DOI":"10.1016\/j.apsb.2024.10.004"},{"key":"1930_CR29","doi-asserted-by":"crossref","unstructured":"Marttinen M, Takalo M, Natunen T, Wittrahm R, Gabbouj S, Kemppainen S et al. Molecular mechanisms of synaptotoxicity and neuroinflammation in Alzheimer\u2019s disease. Front NeuroSci. 2018;12.","DOI":"10.3389\/fnins.2018.00963"},{"issue":"9","key":"1930_CR30","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1002\/1873-3468.14298","volume":"596","author":"D Trigo","year":"2022","unstructured":"Trigo D, Avelar C, Fernandes M, S\u00e1 J. Da Cruz e Silva O. Mitochondria, energy, and metabolism in neuronal health and disease. FEBS Lett. 2022;596(9):1095\u2013110.","journal-title":"FEBS Lett"},{"issue":"1","key":"1930_CR31","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/s41392-023-01486-5","volume":"8","author":"W Zhang","year":"2023","unstructured":"Zhang W, Xiao D, Mao Q, Xia H. Role of neuroinflammation in neurodegeneration development. Signal Transduct Target Therapy. 2023;8(1):267.","journal-title":"Signal Transduct Target Therapy"},{"key":"1930_CR32","doi-asserted-by":"publisher","first-page":"114786","DOI":"10.1016\/j.bcp.2021.114786","volume":"193","author":"JL Green","year":"2021","unstructured":"Green JL, Dos Santos WF, Fontana ACK. Role of glutamate excitotoxicity and glutamate transporter EAAT2 in epilepsy: opportunities for novel therapeutics development. Biochem Pharmacol. 2021;193:114786.","journal-title":"Biochem Pharmacol"},{"key":"1930_CR33","doi-asserted-by":"publisher","first-page":"104605","DOI":"10.1016\/j.msard.2023.104605","volume":"72","author":"GG Davanzo","year":"2023","unstructured":"Davanzo GG, Castro G, Monteiro LB, Castelucci BG, Jaccomo VH, da Silva FC, et al. Obesity increases blood-brain barrier permeability and aggravates the mouse model of multiple sclerosis. Multiple Scler Relat Disorders. 2023;72:104605.","journal-title":"Multiple Scler Relat Disorders"},{"issue":"1","key":"1930_CR34","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/s41392-022-01073-0","volume":"7","author":"M Li","year":"2022","unstructured":"Li M, Chi X, Wang Y, Setrerrahmane S, Xie W, Xu H. Trends in insulin resistance: insights into mechanisms and therapeutic strategy. Signal Transduct Target Therapy. 2022;7(1):216.","journal-title":"Signal Transduct Target Therapy"},{"issue":"3","key":"1930_CR35","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/alzrt265","volume":"6","author":"Y Kitagishi","year":"2014","unstructured":"Kitagishi Y, Nakanishi A, Ogura Y, Matsuda S. Dietary regulation of PI3K\/AKT\/GSK-3\u03b2 pathway in Alzheimer\u2019s disease. Alzheimers Res Ther. 2014;6(3):35.","journal-title":"Alzheimers Res Ther"},{"issue":"5","key":"1930_CR36","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1016\/j.bbadis.2016.08.018","volume":"1863","author":"R Kandimalla","year":"2017","unstructured":"Kandimalla R, Thirumala V, Reddy P. Is Alzheimer\u2019s disease a type 3 diabetes?? A critical appraisal. Biochim Et Biophys Acta (BBA) - Mol Basis Disease. 2017;1863(5):1078\u201389.","journal-title":"Biochim Et Biophys Acta (BBA) - Mol Basis Disease"},{"issue":"4","key":"1930_CR37","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/1753-0407.13252","volume":"14","author":"I Camaya","year":"2022","unstructured":"Camaya I, Donnelly S, O\u2019Brien B. Targeting the PI3K\/Akt signaling pathway in pancreatic \u03b2-cells to enhance their survival and function: an emerging therapeutic strategy for type 1 diabetes. J Diabetes. 2022;14(4):247\u201360.","journal-title":"J Diabetes"},{"issue":"8","key":"1930_CR38","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1002\/cbin.12189","volume":"48","author":"R Taheri","year":"2024","unstructured":"Taheri R, Mokhtari Y, Yousefi A-M, Bashash D. The PI3K\/Akt signaling axis and type 2 diabetes mellitus (T2DM): from mechanistic insights into possible therapeutic targets. Cell Biol Int. 2024;48(8):1049\u201368.","journal-title":"Cell Biol Int"},{"issue":"2","key":"1930_CR39","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/jnc.14829","volume":"151","author":"MP Bordone","year":"2019","unstructured":"Bordone MP, Salman MM, Titus HE, Amini E, Andersen JV, Chakraborti B, et al. The energetic brain \u2013 A review from students to students. J Neurochem. 2019;151(2):139\u201365.","journal-title":"J Neurochem"},{"key":"1930_CR40","doi-asserted-by":"crossref","unstructured":"Clemente-Su\u00e1rez VJ, Redondo-Fl\u00f3rez L, Beltr\u00e1n-Velasco AI, Ramos-Campo DJ, Belinch\u00f3n-deMiguel P, Martinez-Guardado I et al. Mitochondria and brain disease: A comprehensive review of pathological mechanisms and therapeutic opportunities. Biomedicines. 2023;11(9).","DOI":"10.3390\/biomedicines11092488"},{"key":"1930_CR41","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3390\/ijms21228767","volume":"21","author":"NJ Jensen","year":"2020","unstructured":"Jensen NJ, Wodschow HZ, Nilsson M, Rungby J. Effects of ketone bodies on brain metabolism and function in neurodegenerative diseases. Int J Mol Sci. 2020;21:22.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1930_CR42","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s40035-024-00431-y","volume":"13","author":"J Mei","year":"2024","unstructured":"Mei J, Li Y, Niu L, Liang R, Tang M, Cai Q, et al. SGLT2 inhibitors: a novel therapy for cognitive impairment via multifaceted effects on the nervous system. Transl Neurodegener. 2024;13(1):41.","journal-title":"Transl Neurodegener"},{"issue":"1","key":"1930_CR43","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/1752-0509-5-162","volume":"5","author":"S Genc","year":"2011","unstructured":"Genc S, Kurnaz IA, Ozilgen M. Astrocyte - neuron lactate shuttle May boost more ATP supply to the neuron under hypoxic conditions - in Silico study supported by in vitro expression data. BMC Syst Biol. 2011;5(1):162.","journal-title":"BMC Syst Biol"},{"issue":"4","key":"1930_CR44","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/j.cell.2016.07.028","volume":"166","author":"C Garc\u00eda-C\u00e1ceres","year":"2016","unstructured":"Garc\u00eda-C\u00e1ceres C, Quarta C, Varela L, Gao Y, Gruber T, Legutko B, et al. Astrocytic insulin signaling couples brain glucose uptake with nutrient availability. Cell. 2016;166(4):867\u201380.","journal-title":"Cell"},{"key":"1930_CR45","doi-asserted-by":"crossref","unstructured":"Wu A, Lee D, Xiong WC. Lactate metabolism, signaling, and function in brain development, synaptic plasticity, angiogenesis, and neurodegenerative diseases. Int J Mol Sci. 2023;24(17).","DOI":"10.3390\/ijms241713398"},{"key":"1930_CR46","doi-asserted-by":"publisher","first-page":"101999","DOI":"10.1016\/j.arr.2023.101999","volume":"90","author":"Y Tian","year":"2023","unstructured":"Tian Y, Jing G, Zhang M. Insulin-degrading enzyme: roles and pathways in ameliorating cognitive impairment associated with Alzheimer\u2019s disease and diabetes. Ageing Res Rev. 2023;90:101999.","journal-title":"Ageing Res Rev"},{"key":"1930_CR47","doi-asserted-by":"publisher","first-page":"102383","DOI":"10.1016\/j.arr.2024.102383","volume":"99","author":"Y Peng","year":"2024","unstructured":"Peng Y, Yao S-y, Chen Q, Jin H, Du M-q, Xue Y-h, et al. True or false? Alzheimer\u2019s disease is type 3 diabetes: evidences from bench to bedside. Ageing Res Rev. 2024;99:102383.","journal-title":"Ageing Res Rev"},{"issue":"1","key":"1930_CR48","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1186\/s12974-023-02914-7","volume":"20","author":"M Corraliza-Gomez","year":"2023","unstructured":"Corraliza-Gomez M, Bermejo T, Lilue J, Rodriguez-Iglesias N, Valero J, Cozar-Castellano I, et al. Insulin-degrading enzyme (IDE) as a modulator of microglial phenotypes in the context of Alzheimer\u2019s disease and brain aging. J Neuroinflamm. 2023;20(1):233.","journal-title":"J Neuroinflamm"},{"key":"1930_CR49","doi-asserted-by":"crossref","unstructured":"S\u0119dzikowska A, Szablewski L. Insulin and insulin resistance in Alzheimer\u2019s disease. Int J Mol Sci. 2021;22(18).","DOI":"10.3390\/ijms22189987"},{"key":"1930_CR50","doi-asserted-by":"crossref","unstructured":"Benedict C, Grillo CA. Insulin Resistance as a Therapeutic Target in the Treatment of Alzheimer\u2019s Disease: A State-of-the-Art Review. Front NeuroSci. 2018;12.","DOI":"10.3389\/fnins.2018.00215"},{"issue":"1","key":"1930_CR51","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s41983-023-00751-2","volume":"59","author":"J Limantoro","year":"2023","unstructured":"Limantoro J, de Liyis BG, Sutedja JC. Akt signaling pathway: a potential therapy for Alzheimer\u2019s disease through glycogen synthase kinase 3 beta Inhibition. Egypt J Neurol Psychiatry Neurosurg. 2023;59(1):147.","journal-title":"Egypt J Neurol Psychiatry Neurosurg"},{"key":"1930_CR52","doi-asserted-by":"crossref","unstructured":"Yoon JH, Hwang J, Son SU, Choi J, You SW, Park H et al. How Can Insulin Resistance Cause Alzheimer\u2019s Disease? Int J Mol Sci. 2023;24(4).","DOI":"10.3390\/ijms24043506"},{"issue":"8","key":"1930_CR53","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.biopsych.2020.02.001","volume":"89","author":"H Hampel","year":"2021","unstructured":"Hampel H, Vassar R, De Strooper B, Hardy J, Willem M, Singh N, et al. The \u03b2-Secretase BACE1 in Alzheimer\u2019s disease. Biol Psychiatry. 2021;89(8):745\u201356.","journal-title":"Biol Psychiatry"},{"issue":"1","key":"1930_CR54","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s40035-020-00189-z","volume":"9","author":"L Wang","year":"2020","unstructured":"Wang L, Yin Y-L, Liu X-Z, Shen P, Zheng Y-G, Lan X-R, et al. Current Understanding of metal ions in the pathogenesis of Alzheimer\u2019s disease. Translational Neurodegeneration. 2020;9(1):10.","journal-title":"Translational Neurodegeneration"},{"issue":"9","key":"1930_CR55","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1016\/j.bbadis.2014.06.010","volume":"1842","author":"DA Butterfield","year":"2014","unstructured":"Butterfield DA, Di Domenico F, Barone E. Elevated risk of type 2 diabetes for development of Alzheimer disease: A key role for oxidative stress in brain. Biochimica et biophysica acta (BBA) -. Mol Basis Disease. 2014;1842(9):1693\u2013706.","journal-title":"Mol Basis Disease"},{"key":"1930_CR56","doi-asserted-by":"crossref","unstructured":"Cheignon C, Collin F, Sabater L, Hureau C. Oxidative damages on the Alzheimer\u2019s Related-A\u03b2 peptide alters its ability to assemble. Antioxid. 2023;12(2).","DOI":"10.3390\/antiox12020472"},{"key":"1930_CR57","doi-asserted-by":"crossref","unstructured":"Fanlo-Ucar H, Pic\u00f3n-Pag\u00e8s P, Herrera-Fern\u00e1ndez V, Ill-Raga G, Mu\u00f1oz FJ. The dual role of amyloid Beta-Peptide in oxidative stress and inflammation: unveiling their connections in Alzheimer\u2019s disease etiopathology. Antioxid. 2024;13(10).","DOI":"10.3390\/antiox13101208"},{"key":"1930_CR58","doi-asserted-by":"crossref","unstructured":"Tamagno E, Guglielmotto M, Vasciaveo V, Tabaton M. Oxidative Stress and Beta Amyloid in Alzheimer\u2019s Disease. Which Comes First: Chick or Egg? Antioxid (Basel). 2021;10(9).","DOI":"10.3390\/antiox10091479"},{"key":"1930_CR59","doi-asserted-by":"crossref","unstructured":"Philbert SA, Sch\u00f6nberger SJ, Xu J, Church SJ, Unwin RD, Cooper GJS. Elevated hippocampal copper in cases of type 2 diabetes. eBioMedicine. 2022;86.","DOI":"10.1016\/j.ebiom.2022.104317"},{"issue":"5","key":"1930_CR60","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1007\/s11154-024-09908-7","volume":"25","author":"K Sobieska","year":"2024","unstructured":"Sobieska K, Buczy\u0144ska A, Kr\u0119towski AJ, Pop\u0142awska-Kita A. Iron homeostasis and insulin sensitivity: unraveling the complex interactions. Reviews Endocr Metabolic Disorders. 2024;25(5):925\u201339.","journal-title":"Reviews Endocr Metabolic Disorders"},{"issue":"1","key":"1930_CR61","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s12974-023-02853-3","volume":"20","author":"Y Chen","year":"2023","unstructured":"Chen Y, Yu Y. Tau and neuroinflammation in Alzheimer\u2019s disease: interplay mechanisms and clinical translation. J Neuroinflamm. 2023;20(1):165.","journal-title":"J Neuroinflamm"},{"key":"1930_CR62","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3389\/fncel.2019.00017","volume":"13","author":"RA Gon\u00e7alves","year":"2019","unstructured":"Gon\u00e7alves RA, Wijesekara N, Fraser PE, De Felice FG. The link between Tau and insulin signaling: implications for Alzheimer\u2019s disease and other tauopathies. Front Cell Neurosci. 2019;13:17.","journal-title":"Front Cell Neurosci"},{"issue":"5","key":"1930_CR63","first-page":"118664","volume":"1867","author":"E Lauretti","year":"2020","unstructured":"Lauretti E, Dincer O, Pratic\u00f2 D. Glycogen synthase kinase-3 signaling in Alzheimer\u2019s disease. Biochimica et biophysica acta (BBA) -. Mol Cell Res. 2020;1867(5):118664.","journal-title":"Mol Cell Res"},{"issue":"8","key":"1930_CR64","doi-asserted-by":"publisher","first-page":"656","DOI":"10.2174\/156720510793611592","volume":"7","author":"K Iqbal","year":"2010","unstructured":"Iqbal K, Liu F, Gong CX, Grundke-Iqbal I. Tau in Alzheimer disease and related tauopathies. Curr Alzheimer Res. 2010;7(8):656\u201364.","journal-title":"Curr Alzheimer Res"},{"issue":"9","key":"1930_CR65","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1007\/s00018-019-03349-1","volume":"77","author":"CA Brunello","year":"2020","unstructured":"Brunello CA, Merezhko M, Uronen R-L, Huttunen HJ. Mechanisms of secretion and spreading of pathological Tau protein. Cell Mol Life Sci. 2020;77(9):1721\u201344.","journal-title":"Cell Mol Life Sci"},{"issue":"4","key":"1930_CR66","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.biopsych.2017.04.003","volume":"83","author":"JI Ayers","year":"2018","unstructured":"Ayers JI, Giasson BI, Borchelt DR. Prion-like spreading in tauopathies. Biol Psychiatry. 2018;83(4):337\u201346.","journal-title":"Biol Psychiatry"},{"issue":"8","key":"1930_CR67","doi-asserted-by":"publisher","first-page":"ar67","DOI":"10.1091\/mbc.E21-11-0553","volume":"33","author":"L Samluk","year":"2022","unstructured":"Samluk L, Ostapczuk P, Dziembowska M. Long-term mitochondrial stress induces early steps of Tau aggregation by increasing reactive oxygen species levels and affecting cellular proteostasis. Mol Biol Cell. 2022;33(8):ar67.","journal-title":"Mol Biol Cell"},{"issue":"7","key":"1930_CR68","doi-asserted-by":"publisher","first-page":"3617","DOI":"10.1007\/s12035-023-03277-z","volume":"60","author":"PP Guan","year":"2023","unstructured":"Guan PP, Wang P. The involvement of Post-Translational modifications in regulating the development and progression of Alzheimer\u2019s disease. Mol Neurobiol. 2023;60(7):3617\u201332.","journal-title":"Mol Neurobiol"},{"key":"1930_CR69","doi-asserted-by":"crossref","unstructured":"Kelley AR, Bach SBH, Perry G. Analysis of post-translational modifications in Alzheimer\u2019s disease by mass spectrometry. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 2019;1865(8):2040\u20137.","DOI":"10.1016\/j.bbadis.2018.11.002"},{"issue":"1","key":"1930_CR70","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s40035-024-00409-w","volume":"13","author":"N Song","year":"2024","unstructured":"Song N, Mei S, Wang X, Hu G, Lu M. Focusing on mitochondria in the brain: from biology to therapeutics. Translational Neurodegeneration. 2024;13(1):23.","journal-title":"Translational Neurodegeneration"},{"issue":"5","key":"1930_CR71","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1007\/s00204-024-03696-4","volume":"98","author":"K Jomova","year":"2024","unstructured":"Jomova K, Alomar SY, Alwasel SH, Nepovimova E, Kuca K, Valko M. Several lines of antioxidant defense against oxidative stress: antioxidant enzymes, nanomaterials with multiple enzyme-mimicking activities, and low-molecular-weight antioxidants. Arch Toxicol. 2024;98(5):1323\u201367.","journal-title":"Arch Toxicol"},{"key":"1930_CR72","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.freeradbiomed.2021.11.007","volume":"179","author":"A Ayer","year":"2022","unstructured":"Ayer A, Fazakerley DJ, James DE, Stocker R. The role of mitochondrial reactive oxygen species in insulin resistance. Free Radic Biol Med. 2022;179:339\u201362.","journal-title":"Free Radic Biol Med"},{"key":"1930_CR73","doi-asserted-by":"crossref","unstructured":"Liu M, Sun X, Chen B, Dai R, Xi Z, Xu H. Insights into manganese superoxide dismutase and human diseases. Int J Mol Sci. 2022;23(24).","DOI":"10.3390\/ijms232415893"},{"key":"1930_CR74","doi-asserted-by":"crossref","unstructured":"Kitada M, Xu J, Ogura Y, Monno I, Koya D. Manganese superoxide dismutase dysfunction and the pathogenesis of kidney disease. Front Physiol. 2020;11.","DOI":"10.3389\/fphys.2020.00755"},{"issue":"4","key":"1930_CR75","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1152\/physrev.00005.2022","volume":"102","author":"L Piacenza","year":"2022","unstructured":"Piacenza L, Zeida A, Trujillo M, Radi R. The superoxide radical switch in the biology of nitric oxide and peroxynitrite. Physiol Rev. 2022;102(4):1881\u2013906.","journal-title":"Physiol Rev"},{"key":"1930_CR76","doi-asserted-by":"crossref","unstructured":"Olufunmilayo EO, Gerke-Duncan MB, Holsinger RMD. Oxidative stress and antioxidants in neurodegenerative disorders. Antioxid. 2023;12(2).","DOI":"10.3390\/antiox12020517"},{"issue":"1","key":"1930_CR77","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1038\/s41392-023-01503-7","volume":"8","author":"S Wang","year":"2023","unstructured":"Wang S, Long H, Hou L, Feng B, Ma Z, Wu Y, et al. The mitophagy pathway and its implications in human diseases. Signal Transduct Target Therapy. 2023;8(1):304.","journal-title":"Signal Transduct Target Therapy"},{"key":"1930_CR78","doi-asserted-by":"crossref","unstructured":"Tang S, Geng Y, Lin Q. The role of mitophagy in metabolic diseases and its exercise intervention. Front Physiol. 2024;15.","DOI":"10.3389\/fphys.2024.1339128"},{"key":"1930_CR79","doi-asserted-by":"crossref","unstructured":"Xiao B, Goh J-Y, Xiao L, Xian H, Lim K-L, Liou Y-C. Reactive oxygen species trigger Parkin\/PINK1 pathway\u2013dependent mitophagy by inducing mitochondrial recruitment of Parkin. Journal of Biological Chemistry. 2017;292(40):16697-708.","DOI":"10.1074\/jbc.M117.787739"},{"issue":"1","key":"1930_CR80","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12915-017-0470-7","volume":"16","author":"S Sekine","year":"2018","unstructured":"Sekine S, Youle RJ. PINK1 import regulation; a fine system to convey mitochondrial stress to the cytosol. BMC Biol. 2018;16(1):2.","journal-title":"BMC Biol"},{"issue":"6","key":"1930_CR81","doi-asserted-by":"publisher","first-page":"e3002196","DOI":"10.1371\/journal.pbio.3002196","volume":"21","author":"B O\u2019Callaghan","year":"2023","unstructured":"O\u2019Callaghan B, Hardy J, Plun-Favreau H. PINK1: from parkinson\u2019s disease to mitophagy and back again. PLoS Biol. 2023;21(6):e3002196.","journal-title":"PLoS Biol"},{"key":"1930_CR82","doi-asserted-by":"crossref","unstructured":"Mahmoud S, Gharagozloo M, Simard C, Gris D. Astrocytes maintain glutamate homeostasis in the CNS by controlling the balance between glutamate uptake and release. Cells. 2019;8(2).","DOI":"10.3390\/cells8020184"},{"issue":"1","key":"1930_CR83","doi-asserted-by":"publisher","first-page":"E27","DOI":"10.1152\/ajpendo.00069.2024","volume":"327","author":"A Galli","year":"2024","unstructured":"Galli A, Moretti S, Dule N, Di Cairano ES, Castagna M, Marciani P, et al. Hyperglycemia impairs EAAT2 glutamate transporter trafficking and glutamate clearance in Islets of langerhans: implications for type 2 diabetes pathogenesis and treatment. Am J Physiology-Endocrinology Metabolism. 2024;327(1):E27\u201341.","journal-title":"Am J Physiology-Endocrinology Metabolism"},{"issue":"1","key":"1930_CR84","doi-asserted-by":"publisher","first-page":"4714","DOI":"10.1038\/s41467-022-32442-6","volume":"13","author":"T Kato","year":"2022","unstructured":"Kato T, Kusakizako T, Jin C, Zhou X, Ohgaki R, Quan L, et al. Structural insights into inhibitory mechanism of human excitatory amino acid transporter EAAT2. Nat Commun. 2022;13(1):4714.","journal-title":"Nat Commun"},{"key":"1930_CR85","doi-asserted-by":"crossref","unstructured":"Philippens IHCHM. Chapter 23 - Marmosets in Neurologic Disease Research: Parkinson\u2019s Disease. In: Marini R, Wachtman L, Tardif S, Mansfield K, Fox J, editors. The common marmoset in captivity and biomedical research. Academic; 2019. pp. 415\u201335.","DOI":"10.1016\/B978-0-12-811829-0.00023-6"},{"issue":"1","key":"1930_CR86","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13041-018-0357-8","volume":"11","author":"QJ Wu","year":"2018","unstructured":"Wu QJ, Tymianski M. Targeting NMDA receptors in stroke: new hope in neuroprotection. Mol Brain. 2018;11(1):15.","journal-title":"Mol Brain"},{"issue":"9","key":"1930_CR87","doi-asserted-by":"publisher","first-page":"e209378","DOI":"10.1212\/WNL.0000000000209378","volume":"102","author":"E Benarroch","year":"2024","unstructured":"Benarroch E. What is the role of lactate in brain metabolism, plasticity, and neurodegeneration?? Neurology. 2024;102(9):e209378.","journal-title":"Neurology"},{"key":"1930_CR88","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.neuroscience.2021.11.035","volume":"481","author":"K Yamagata","year":"2022","unstructured":"Yamagata K. Lactate supply from astrocytes to neurons and its role in ischemic Stroke-induced neurodegeneration. Neuroscience. 2022;481:219\u201331.","journal-title":"Neuroscience"},{"issue":"3","key":"1930_CR89","doi-asserted-by":"publisher","first-page":"779","DOI":"10.4103\/NRR.NRR-D-23-01508","volume":"20","author":"G Zhang","year":"2025","unstructured":"Zhang G, Yao Q, Long C, Yi P, Song J, Wu L, et al. Infiltration by monocytes of the central nervous system and its role in multiple sclerosis: reflections on therapeutic strategies. Neural Regen Res. 2025;20(3):779\u201393.","journal-title":"Neural Regen Res"},{"key":"1930_CR90","doi-asserted-by":"crossref","unstructured":"Calkin C, McClelland C, Cairns K, Kamintsky L, Friedman A. Insulin resistance and Blood-Brain barrier dysfunction underlie neuroprogression in bipolar disorder. Front Psychiatry. 2021;12.","DOI":"10.3389\/fpsyt.2021.636174"},{"key":"1930_CR91","doi-asserted-by":"publisher","first-page":"914","DOI":"10.3389\/fphys.2020.00914","volume":"11","author":"JJ Lochhead","year":"2020","unstructured":"Lochhead JJ, Yang J, Ronaldson PT, Davis TP. Structure, function, and regulation of the Blood-Brain barrier tight junction in central nervous system disorders. Front Physiol. 2020;11:914.","journal-title":"Front Physiol"},{"key":"1930_CR92","doi-asserted-by":"crossref","unstructured":"Wicks EE, Ran KR, Kim JE, Xu R, Lee RP, Jackson CM. The translational potential of microglia and Monocyte-Derived macrophages in ischemic stroke. Front Immunol. 2022;13.","DOI":"10.3389\/fimmu.2022.897022"},{"issue":"1","key":"1930_CR93","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1002\/alz.13490","volume":"20","author":"S Gaikwad","year":"2024","unstructured":"Gaikwad S, Senapati S, Haque MA, Kayed R. Senescence, brain inflammation, and oligomeric Tau drive cognitive decline in Alzheimer\u2019s disease: evidence from clinical and preclinical studies. Alzheimers Dement. 2024;20(1):709\u201327.","journal-title":"Alzheimers Dement"},{"key":"1930_CR94","doi-asserted-by":"publisher","first-page":"110804","DOI":"10.1016\/j.diabres.2023.110804","volume":"202","author":"P Hoorzad","year":"2023","unstructured":"Hoorzad P, Mousavinasab F, Tofigh P, Kalahroud EM, Aghaei-Zarch SM, Salehi A, et al. Understanding the lncRNA\/miRNA-NF\u03baB regulatory network in diabetes mellitus: from function to clinical translation. Diabetes Res Clin Pract. 2023;202:110804.","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"1930_CR95","doi-asserted-by":"publisher","first-page":"e001821","DOI":"10.1136\/bmjdrc-2020-001821","volume":"9","author":"A Mohammed","year":"2021","unstructured":"Mohammed A, Mirza Masroor Ali B, Mohammad Yahya A, Irfan A, Ali Gaithan A, Prakash CJ, et al. Circulating long non-coding RNAs NKILA, NEAT1, MALAT1, and MIAT expression and their association in type 2 diabetes mellitus. BMJ Open Diabetes Res Care. 2021;9(1):e001821.","journal-title":"BMJ Open Diabetes Res Care"},{"key":"1930_CR96","doi-asserted-by":"crossref","unstructured":"Yang W, Lyu Y, Xiang R, Yang J. Long noncoding RNAs in the pathogenesis of insulin resistance. Int J Mol Sci. 2022;23(24).","DOI":"10.3390\/ijms232416054"},{"key":"1930_CR97","doi-asserted-by":"publisher","first-page":"602597","DOI":"10.3389\/fendo.2021.602597","volume":"12","author":"C Dieter","year":"2021","unstructured":"Dieter C, Lemos NE, Corr\u00eaa NRF, Assmann TS, Crispim D. The impact of LncRNAs in diabetes mellitus: A systematic review and in Silico analyses. Front Endocrinol (Lausanne). 2021;12:602597.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1930_CR98","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.ejphar.2017.06.018","volume":"817","author":"S Musardo","year":"2017","unstructured":"Musardo S, Marcello E. Synaptic dysfunction in Alzheimer\u2019s disease: from the role of amyloid \u03b2-peptide to the \u03b1-secretase ADAM10. Eur J Pharmacol. 2017;817:30\u20137.","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"1930_CR99","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.3892\/mmr.2014.2351","volume":"10","author":"T Liu","year":"2014","unstructured":"Liu T, Huang Y, Chen J, Chi H, Yu Z, Wang J, et al. Attenuated ability of BACE1 to cleave the amyloid precursor protein via Silencing long noncoding RNA BACE1\u2013AS expression. Mol Med Rep. 2014;10(3):1275\u201381.","journal-title":"Mol Med Rep"},{"issue":"7","key":"1930_CR100","doi-asserted-by":"publisher","first-page":"6007","DOI":"10.1007\/s12035-017-0820-z","volume":"55","author":"T Zhang","year":"2018","unstructured":"Zhang T, Pang P, Fang Z, Guo Y, Li H, Li X, et al. Expression of BC1 impairs Spatial learning and memory in Alzheimer\u2019s disease via APP translation. Mol Neurobiol. 2018;55(7):6007\u201320.","journal-title":"Mol Neurobiol"},{"issue":"2","key":"1930_CR101","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.ncrna.2020.03.001","volume":"5","author":"VA Tello-Flores","year":"2020","unstructured":"Tello-Flores VA, Valladares-Salgado A, Ram\u00edrez-Vargas MA, Cruz M, del-Moral-Hern\u00e1ndez O, Cahua-Pablo J\u00c1, et al. Altered levels of MALAT1 and H19 derived from serum or serum exosomes associated with type-2 diabetes. Non-coding RNA Res. 2020;5(2):71\u20136.","journal-title":"Non-coding RNA Res"},{"issue":"1","key":"1930_CR102","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s10020-022-00507-3","volume":"28","author":"A Kumar","year":"2022","unstructured":"Kumar A, Datta M. H19 Inhibition increases HDAC6 and regulates IRS1 levels and insulin signaling in the skeletal muscle during diabetes. Mol Med. 2022;28(1):81.","journal-title":"Mol Med"},{"key":"1930_CR103","doi-asserted-by":"publisher","first-page":"102989","DOI":"10.1016\/j.redox.2023.102989","volume":"69","author":"A Nandwani","year":"2024","unstructured":"Nandwani A, Rathore S, Datta M. LncRNA H19 Inhibition impairs Endoplasmic reticulum-mitochondria contact in hepatic cells and augments gluconeogenesis by increasing VDAC1 levels. Redox Biol. 2024;69:102989.","journal-title":"Redox Biol"},{"issue":"4","key":"1930_CR104","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1016\/j.gendis.2023.02.008","volume":"10","author":"J Liao","year":"2023","unstructured":"Liao J, Chen B, Zhu Z, Du C, Gao S, Zhao G, et al. Long noncoding RNA (lncRNA) H19: an essential developmental regulator with expanding roles in cancer, stem cell differentiation, and metabolic diseases. Genes Dis. 2023;10(4):1351\u201366.","journal-title":"Genes Dis"},{"issue":"1","key":"1930_CR105","doi-asserted-by":"publisher","first-page":"17490","DOI":"10.1038\/s41598-017-17718-y","volume":"7","author":"M Gejl","year":"2017","unstructured":"Gejl M, Brock B, Egefjord L, Vang K, Rungby J, Gjedde A. Blood-Brain glucose transfer in Alzheimer\u2019s disease: effect of GLP-1 analog treatment. Sci Rep. 2017;7(1):17490.","journal-title":"Sci Rep"},{"issue":"11","key":"1930_CR106","doi-asserted-by":"publisher","first-page":"4097","DOI":"10.1074\/jbc.M117.812818","volume":"293","author":"X Cui","year":"2018","unstructured":"Cui X, Tan J, Shi Y, Sun C, Li Y, Ji C, et al. The long non-coding RNA Gm10768 activates hepatic gluconeogenesis by sequestering microRNA-214 in mice. J Biol Chem. 2018;293(11):4097\u2013109.","journal-title":"J Biol Chem"},{"issue":"1","key":"1930_CR107","doi-asserted-by":"publisher","first-page":"8312","DOI":"10.1038\/s41598-017-08281-7","volume":"7","author":"N Goyal","year":"2017","unstructured":"Goyal N, Sivadas A, Shamsudheen KV, Jayarajan R, Verma A, Sivasubbu S, et al. RNA sequencing of db\/db mice liver identifies LncRNA H19 as a key regulator of gluconeogenesis and hepatic glucose output. Sci Rep. 2017;7(1):8312.","journal-title":"Sci Rep"},{"issue":"19","key":"1930_CR108","doi-asserted-by":"publisher","first-page":"13000","DOI":"10.1074\/jbc.M114.564658","volume":"289","author":"S Liu","year":"2014","unstructured":"Liu S, Sheng L, Miao H, Saunders TL, MacDougald OA, Koenig RJ, et al. SRA gene knockout protects against diet-induced obesity and improves glucose tolerance. J Biol Chem. 2014;289(19):13000\u20139.","journal-title":"J Biol Chem"},{"key":"1930_CR109","doi-asserted-by":"publisher","first-page":"22640","DOI":"10.1038\/srep22640","volume":"6","author":"C Yan","year":"2016","unstructured":"Yan C, Chen J, Chen N. Long noncoding RNA MALAT1 promotes hepatic steatosis and insulin resistance by increasing nuclear SREBP-1c protein stability. Sci Rep. 2016;6:22640.","journal-title":"Sci Rep"},{"key":"1930_CR110","doi-asserted-by":"crossref","unstructured":"Kim YK, Song J. The Role of Long Noncoding RNAs in Diabetic Alzheimer\u2019s Disease. J Clin Med. 2018;7(11).","DOI":"10.3390\/jcm7110461"},{"issue":"1","key":"1930_CR111","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1261\/rna.079436.122","volume":"29","author":"N Was","year":"2022","unstructured":"Was N, Sauer M, Fischer U, Becker M. LncRNA Malat1 and miR-26 cooperate in the regulation of neuronal progenitor cell proliferation and differentiation. RNA. 2022;29(1):69\u201381.","journal-title":"RNA"},{"issue":"2","key":"1930_CR112","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/jre.12700","volume":"55","author":"J Li","year":"2020","unstructured":"Li J, Wang M, Song L, Wang X, Lai W, Jiang S. LncRNA MALAT1 regulates inflammatory cytokine production in lipopolysaccharide-stimulated human gingival fibroblasts through sponging miR-20a and activating TLR4 pathway. J Periodontal Res. 2020;55(2):182\u201390.","journal-title":"J Periodontal Res"},{"issue":"5","key":"1930_CR113","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1101\/gad.273821.115","volume":"30","author":"L Arnes","year":"2016","unstructured":"Arnes L, Akerman I, Balderes DA, Ferrer J, Sussel L. \u03b2linc1 encodes a long noncoding RNA that regulates islet \u03b2-cell formation and function. Genes Dev. 2016;30(5):502\u20137.","journal-title":"Genes Dev"},{"issue":"9","key":"1930_CR114","doi-asserted-by":"publisher","first-page":"3133","DOI":"10.1096\/fj.201500058R","volume":"30","author":"Y Wang","year":"2016","unstructured":"Wang Y, Hu Y, Sun C, Zhuo S, He Z, Wang H, et al. Down-regulation of Risa improves insulin sensitivity by enhancing autophagy. Faseb J. 2016;30(9):3133\u201345.","journal-title":"Faseb J"},{"issue":"11","key":"1930_CR115","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.1111\/jcmm.12904","volume":"20","author":"L Chen","year":"2016","unstructured":"Chen L, Feng P, Zhu X, He S, Duan J, Zhou D. Long non-coding RNA Malat1 promotes neurite outgrowth through activation of ERK\/MAPK signalling pathway in N2a cells. J Cell Mol Med. 2016;20(11):2102\u201310.","journal-title":"J Cell Mol Med"},{"key":"1930_CR116","doi-asserted-by":"publisher","first-page":"1400533","DOI":"10.3389\/fimmu.2024.1400533","volume":"15","author":"I Kerkis","year":"2024","unstructured":"Kerkis I, da Silva \u00c1P, Araldi RP. The impact of interleukin-6 (IL-6) and mesenchymal stem cell-derived IL-6 on neurological conditions. Front Immunol. 2024;15:1400533.","journal-title":"Front Immunol"},{"issue":"2","key":"1930_CR117","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.bbrc.2015.11.048","volume":"469","author":"X Zhu","year":"2016","unstructured":"Zhu X, Wu YB, Zhou J, Kang DM. Upregulation of LncRNA MEG3 promotes hepatic insulin resistance via increasing FoxO1 expression. Biochem Biophys Res Commun. 2016;469(2):319\u201325.","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"1930_CR118","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1002\/jcp.25175","volume":"231","author":"L You","year":"2016","unstructured":"You L, Wang N, Yin D, Wang L, Jin F, Zhu Y, et al. Downregulation of long noncoding RNA Meg3 affects insulin synthesis and secretion in mouse pancreatic beta cells. J Cell Physiol. 2016;231(4):852\u201362.","journal-title":"J Cell Physiol"},{"key":"1930_CR119","doi-asserted-by":"publisher","first-page":"101425","DOI":"10.1016\/j.arr.2021.101425","volume":"71","author":"E Lauretti","year":"2021","unstructured":"Lauretti E, Dabrowski K, Pratic\u00f2 D. The neurobiology of non-coding RNAs and Alzheimer\u2019s disease pathogenesis: pathways, mechanisms and translational opportunities. Ageing Res Rev. 2021;71:101425.","journal-title":"Ageing Res Rev"},{"issue":"6","key":"1930_CR120","doi-asserted-by":"publisher","first-page":"107313","DOI":"10.1016\/j.jbc.2024.107313","volume":"300","author":"JM Cooper","year":"2024","unstructured":"Cooper JM, Lathuiliere A, Su EJ, Song Y, Torrente D, Jo Y, et al. SORL1 is a receptor for Tau that promotes Tau seeding. J Biol Chem. 2024;300(6):107313.","journal-title":"J Biol Chem"},{"key":"1930_CR121","doi-asserted-by":"crossref","unstructured":"Black CM, Braden AA, Nasim S, Tripathi M, Xiao J, Khan MM. The association between long Non-Coding RNAs and Alzheimer\u2019s disease. Brain Sci. 2024;14(8).","DOI":"10.3390\/brainsci14080818"},{"issue":"1","key":"1930_CR122","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12867-019-0140-0","volume":"20","author":"F Li","year":"2019","unstructured":"Li F, Wang Y, Yang H, Xu Y, Zhou X, Zhang X, et al. The effect of BACE1-AS on \u03b2-amyloid generation by regulating BACE1 mRNA expression. BMC Mol Biol. 2019;20(1):23.","journal-title":"BMC Mol Biol"},{"issue":"Supplement2","key":"1930_CR123","doi-asserted-by":"publisher","first-page":"ehac5442945","DOI":"10.1093\/eurheartj\/ehac544.2945","volume":"43","author":"S Greco","year":"2022","unstructured":"Greco S, Piella SN, Made A, Tascini AS, Garcia-Manteiga JM, Castelvecchio S, et al. LncRNA BACE1-AS: a link between heart failure and Alzheimer\u2019s disease. Eur Heart J. 2022;43(Supplement2):ehac5442945.","journal-title":"Eur Heart J"},{"issue":"8","key":"1930_CR124","doi-asserted-by":"publisher","first-page":"107510","DOI":"10.1016\/j.jbc.2024.107510","volume":"300","author":"I Ulku","year":"2024","unstructured":"Ulku I, Leung R, Herre F, Walther L, Shobo A, Saftig P, et al. Inhibition of BACE1 affected both its A\u03b2 producing and degrading activities and increased A\u03b242 and A\u03b240 levels at high-level BACE1 expression. J Biol Chem. 2024;300(8):107510.","journal-title":"J Biol Chem"},{"key":"1930_CR125","doi-asserted-by":"crossref","unstructured":"Sayad A, Najafi S, Hussen BM, Abdullah ST, Movahedpour A, Taheri M et al. The emerging roles of the \u03b2-Secretase BACE1 and the long Non-coding RNA BACE1-AS in human diseases: A focus on neurodegenerative diseases and cancer. Front Aging Neurosci. 2022;14.","DOI":"10.3389\/fnagi.2022.853180"},{"key":"1930_CR126","doi-asserted-by":"publisher","first-page":"821002","DOI":"10.3389\/fnmol.2021.821002","volume":"14","author":"Z Lan","year":"2021","unstructured":"Lan Z, Chen Y, Jin J, Xu Y, Zhu X. Long Non-coding RNA: insight into mechanisms of Alzheimer\u2019s disease. Front Mol Neurosci. 2021;14:821002.","journal-title":"Front Mol Neurosci"},{"key":"1930_CR127","doi-asserted-by":"crossref","unstructured":"Anilkumar AK, Vij P, Lopez S, Leslie SM, Doxtater K, Khan MM et al. Long Non-Coding rnas: new insights in neurodegenerative diseases. Int J Mol Sci. 2024;25(4).","DOI":"10.3390\/ijms25042268"},{"key":"1930_CR128","doi-asserted-by":"crossref","unstructured":"Hao Y, Xie B, Fu X, Xu R, Yang Y. New insights into LncRNAs in A\u03b2 cascade hypothesis of Alzheimer\u2019s disease. Biomolecules. 2022;12(12).","DOI":"10.3390\/biom12121802"},{"issue":"3","key":"1930_CR129","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.ncrna.2024.03.008","volume":"9","author":"X Wu","year":"2024","unstructured":"Wu X, Xia P, Yang L, Lu C, Lu Z. The roles of long non-coding RNAs in Alzheimer\u2019s disease diagnosis, treatment, and their involvement in Alzheimer\u2019s disease immune responses. Noncoding RNA Res. 2024;9(3):659\u201366.","journal-title":"Noncoding RNA Res"},{"key":"1930_CR130","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.semcdb.2022.05.028","volume":"139","author":"J Griffiths","year":"2023","unstructured":"Griffiths J, Grant SGN. Synapse pathology in Alzheimer\u2019s disease. Semin Cell Dev Biol. 2023;139:13\u201323.","journal-title":"Semin Cell Dev Biol"},{"key":"1930_CR131","doi-asserted-by":"publisher","first-page":"18144","DOI":"10.1038\/srep18144","volume":"5","author":"S Vella","year":"2015","unstructured":"Vella S, Penna I, Longo L, Pioggia G, Garbati P, Florio T, et al. Perhexiline maleate enhances antitumor efficacy of cisplatin in neuroblastoma by inducing over-expression of NDM29 NcRNA. Sci Rep. 2015;5:18144.","journal-title":"Sci Rep"},{"issue":"7","key":"1930_CR132","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/nri3705","volume":"14","author":"MT Heneka","year":"2014","unstructured":"Heneka MT, Kummer MP, Latz E. Innate immune activation in neurodegenerative disease. Nat Rev Immunol. 2014;14(7):463\u201377.","journal-title":"Nat Rev Immunol"},{"key":"1930_CR133","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.neuroscience.2016.01.033","volume":"319","author":"R Chen","year":"2016","unstructured":"Chen R, Liu L, Xiao M, Wang F, Lin X. Microarray expression profile analysis of long noncoding RNAs in premature brain injury: A novel point of view. Neuroscience. 2016;319:123\u201333.","journal-title":"Neuroscience"},{"issue":"1","key":"1930_CR134","doi-asserted-by":"publisher","first-page":"3979","DOI":"10.1038\/ncomms4979","volume":"5","author":"NE Ilott","year":"2014","unstructured":"Ilott NE, Heward JA, Roux B, Tsitsiou E, Fenwick PS, Lenzi L, et al. Long non-coding RNAs and enhancer RNAs regulate the lipopolysaccharide-induced inflammatory response in human monocytes. Nat Commun. 2014;5(1):3979.","journal-title":"Nat Commun"},{"key":"1930_CR135","doi-asserted-by":"crossref","unstructured":"Wang H, Liu F, Chen W, Sun X, Cui W, Dong Z et al. Genetic recovery of ErbB4 in adulthood partially restores brain functions in null mice. Proceedings of the National Academy of Sciences. 2018;115(51):13105-10.","DOI":"10.1073\/pnas.1811287115"},{"issue":"8","key":"1930_CR136","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1161\/STROKEAHA.117.017387","volume":"48","author":"J Wang","year":"2017","unstructured":"Wang J, Zhao H, Fan Z, Li G, Ma Q, Tao Z, et al. Long noncoding RNA H19 promotes neuroinflammation in ischemic stroke by driving histone deacetylase 1-Dependent M1 microglial polarization. Stroke. 2017;48(8):2211\u201321.","journal-title":"Stroke"},{"key":"1930_CR137","doi-asserted-by":"crossref","unstructured":"Guo S, Wang H, Yin Y. Microglia polarization from M1 to M2 in neurodegenerative diseases. Front Aging Neurosci. 2022;14.","DOI":"10.3389\/fnagi.2022.815347"},{"key":"1930_CR138","doi-asserted-by":"crossref","unstructured":"Rybak-Wolf A, Plass M. RNA dynamics in Alzheimer\u2019s disease. Molecules. 2021;26(17).","DOI":"10.3390\/molecules26175113"},{"issue":"1","key":"1930_CR139","doi-asserted-by":"publisher","first-page":"2621","DOI":"10.1038\/s41598-019-39191-5","volume":"9","author":"JJ Lochhead","year":"2019","unstructured":"Lochhead JJ, Kellohen KL, Ronaldson PT, Davis TP. Distribution of insulin in trigeminal nerve and brain after intranasal administration. Sci Rep. 2019;9(1):2621.","journal-title":"Sci Rep"},{"key":"1930_CR140","doi-asserted-by":"publisher","first-page":"113370","DOI":"10.1016\/j.physbeh.2021.113370","volume":"234","author":"JM Erichsen","year":"2021","unstructured":"Erichsen JM, Calva CB, Reagan LP, Fadel JR. Intranasal insulin and orexins to treat age-related cognitive decline. Physiol Behav. 2021;234:113370.","journal-title":"Physiol Behav"},{"key":"1930_CR141","doi-asserted-by":"crossref","unstructured":"Oh YS, Jun H-S. Effects of Glucagon-Like Peptide-1 on oxidative stress and Nrf2 signaling. Int J Mol Sci. 2017;19.","DOI":"10.3390\/ijms19010026"},{"issue":"5","key":"1930_CR142","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.drudis.2016.01.013","volume":"21","author":"D Athauda","year":"2016","unstructured":"Athauda D, Foltynie T. The glucagon-like peptide 1 (GLP) receptor as a therapeutic target in parkinson\u2019s disease: mechanisms of action. Drug Discovery Today. 2016;21(5):802\u201318.","journal-title":"Drug Discovery Today"},{"key":"1930_CR143","doi-asserted-by":"publisher","first-page":"1022739","DOI":"10.3389\/fgene.2022.1022739","volume":"13","author":"S Goel","year":"2022","unstructured":"Goel S, Singh R, Singh V, Singh H, Kumari P, Chopra H, et al. Metformin: activation of 5\u2019 AMP-activated protein kinase and its emerging potential beyond anti-hyperglycemic action. Front Genet. 2022;13:1022739.","journal-title":"Front Genet"},{"issue":"2","key":"1930_CR144","first-page":"99","volume":"29","author":"DG Hardie","year":"2014","unstructured":"Hardie DG, Ashford ML. AMPK: regulating energy balance at the cellular and whole body levels. Physiol (Bethesda). 2014;29(2):99\u2013107.","journal-title":"Physiol (Bethesda)"},{"key":"1930_CR145","doi-asserted-by":"publisher","first-page":"116373","DOI":"10.1016\/j.biopha.2024.116373","volume":"173","author":"Z Zhao","year":"2024","unstructured":"Zhao Z, Yan J, Huang L, Yang X. Phytochemicals targeting Alzheimer\u2019s disease via the AMP-activated protein kinase pathway, effects, and mechanisms of action. Biomed Pharmacother. 2024;173:116373.","journal-title":"Biomed Pharmacother"},{"key":"1930_CR146","doi-asserted-by":"crossref","unstructured":"Ruegsegger GN, Vanderboom PM, Dasari S, Klaus KA, Kabiraj P, McCarthy CB et al. Exercise and Metformin counteract altered mitochondrial function in the insulin-resistant brain. JCI Insight. 2019;4(18).","DOI":"10.1172\/jci.insight.130681"},{"issue":"5","key":"1930_CR147","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1089\/ars.2021.0019","volume":"35","author":"AM de Mara\u00f1\u00f3n","year":"2021","unstructured":"de Mara\u00f1\u00f3n AM, Canet F, Abad-Jim\u00e9nez Z, Jover A, Morillas C, Rocha M, et al. Does Metformin modulate mitochondrial dynamics and function in type 2 diabetic patients?? Antioxid Redox Signal. 2021;35(5):377\u201385.","journal-title":"Antioxid Redox Signal"},{"key":"1930_CR148","doi-asserted-by":"publisher","first-page":"832707","DOI":"10.3389\/fphar.2022.832707","volume":"13","author":"Y Hu","year":"2022","unstructured":"Hu Y, Zhou Y, Yang Y, Tang H, Si Y, Chen Z, et al. Metformin protects against Diabetes-Induced cognitive dysfunction by inhibiting mitochondrial fission protein DRP1. Front Pharmacol. 2022;13:832707.","journal-title":"Front Pharmacol"},{"issue":"1","key":"1930_CR149","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s12974-024-03072-0","volume":"21","author":"M Wang","year":"2024","unstructured":"Wang M, Tian T, Zhou H, Jiang SY, Jiao YY, Zhu Z, et al. Metformin normalizes mitochondrial function to delay astrocyte senescence in a mouse model of parkinson\u2019s disease through Mfn2-cGAS signaling. J Neuroinflammation. 2024;21(1):81.","journal-title":"J Neuroinflammation"},{"key":"1930_CR150","doi-asserted-by":"crossref","unstructured":"Chhunchha B, Kubo E, Singh DP. Obligatory Role of AMPK Activation and Antioxidant Defense Pathway in the Regulatory Effects of Metformin on Cellular Protection and Prevention of Lens Opacity. Cells. 2022;11(19).","DOI":"10.3390\/cells11193021"},{"key":"1930_CR151","doi-asserted-by":"crossref","unstructured":"Hammad M, Raftari M, Ces\u00e1rio R, Salma R, Godoy P, Emami SN et al. Roles of oxidative stress and Nrf2 signaling in pathogenic and Non-Pathogenic cells: A possible general mechanism of resistance to therapy. Antioxid (Basel). 2023;12(7).","DOI":"10.3390\/antiox12071371"},{"key":"1930_CR152","doi-asserted-by":"publisher","first-page":"113686","DOI":"10.1016\/j.biopha.2022.113686","volume":"156","author":"G Cao","year":"2022","unstructured":"Cao G, Gong T, Du Y, Wang Y, Ge T, Liu J. Mechanism of Metformin regulation in central nervous system: progression and future perspectives. Biomed Pharmacother. 2022;156:113686.","journal-title":"Biomed Pharmacother"},{"issue":"6","key":"1930_CR153","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1038\/s12276-020-0456-3","volume":"52","author":"C Hall","year":"2020","unstructured":"Hall C, Yu H, Choi E. Insulin receptor endocytosis in the pathophysiology of insulin resistance. Exp Mol Med. 2020;52(6):911\u201320.","journal-title":"Exp Mol Med"},{"key":"1930_CR154","doi-asserted-by":"crossref","unstructured":"Gabbouj S, Ryh\u00e4nen S, Marttinen M, Wittrahm R, Takalo M, Kemppainen S et al. Altered insulin signaling in Alzheimer\u2019s disease Brain \u2013 Special emphasis on PI3K-Akt pathway. Front NeuroSci. 2019;13.","DOI":"10.3389\/fnins.2019.00629"},{"issue":"11","key":"1930_CR155","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.7150\/ijbs.27173","volume":"14","author":"X Huang","year":"2018","unstructured":"Huang X, Liu G, Guo J, Su Z. The PI3K\/AKT pathway in obesity and type 2 diabetes. Int J Biol Sci. 2018;14(11):1483\u201396.","journal-title":"Int J Biol Sci"},{"key":"1930_CR156","doi-asserted-by":"publisher","first-page":"114244","DOI":"10.1016\/j.biopha.2023.114244","volume":"159","author":"MS Savova","year":"2023","unstructured":"Savova MS, Mihaylova LV, Tews D, Wabitsch M, Georgiev MI. Targeting PI3K\/AKT signaling pathway in obesity. Biomed Pharmacother. 2023;159:114244.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"1930_CR157","doi-asserted-by":"publisher","first-page":"317","DOI":"10.3892\/mmr.2020.11105","volume":"22","author":"M Liu","year":"2020","unstructured":"Liu M, Huang X, Tian Y, Yan X, Wang F, Chen J, et al. Phosphorylated GSK\u20133\u03b2 protects stress\u2013induced apoptosis of myoblasts via the PI3K\/Akt signaling pathway. Mol Med Rep. 2020;22(1):317\u201327.","journal-title":"Mol Med Rep"},{"issue":"1","key":"1930_CR158","doi-asserted-by":"publisher","first-page":"35660","DOI":"10.1038\/srep35660","volume":"6","author":"L Romorini","year":"2016","unstructured":"Romorini L, Garate X, Neiman G, Luzzani C, Furmento VA, Guberman AS, et al. AKT\/GSK3\u03b2 signaling pathway is critically involved in human pluripotent stem cell survival. Sci Rep. 2016;6(1):35660.","journal-title":"Sci Rep"},{"issue":"1","key":"1930_CR159","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/s41392-023-01608-z","volume":"8","author":"V Panwar","year":"2023","unstructured":"Panwar V, Singh A, Bhatt M, Tonk RK, Azizov S, Raza AS, et al. Multifaceted role of mTOR (mammalian target of rapamycin) signaling pathway in human health and disease. Signal Transduct Target Therapy. 2023;8(1):375.","journal-title":"Signal Transduct Target Therapy"},{"key":"1930_CR160","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/B978-0-12-394447-4.30015-3","volume-title":"Encyclopedia of cell biology","author":"C Evangelisti","year":"2016","unstructured":"Evangelisti C, Martelli AM. The PI3K\/Akt\/mTOR pathway. In: Bradshaw RA, Stahl PD, editors. Encyclopedia of cell biology. Waltham: Academic; 2016. pp. 128\u201335."},{"key":"1930_CR161","doi-asserted-by":"publisher","first-page":"101464","DOI":"10.1016\/j.arr.2021.101464","volume":"72","author":"Z Zhang","year":"2021","unstructured":"Zhang Z, Yang X, Song Y-Q, Tu J. Autophagy in Alzheimer\u2019s disease pathogenesis: therapeutic potential and future perspectives. Ageing Res Rev. 2021;72:101464.","journal-title":"Ageing Res Rev"},{"key":"1930_CR162","doi-asserted-by":"publisher","first-page":"1281338","DOI":"10.3389\/fnagi.2023.1281338","volume":"15","author":"H Barmaki","year":"2023","unstructured":"Barmaki H, Nourazarian A, Khaki-Khatibi F. Proteostasis and neurodegeneration: a closer look at autophagy in Alzheimer\u2019s disease. Front Aging Neurosci. 2023;15:1281338.","journal-title":"Front Aging Neurosci"},{"key":"1930_CR163","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1749-8104-5-7","volume":"5","author":"SL Chiu","year":"2010","unstructured":"Chiu SL, Cline HT. Insulin receptor signaling in the development of neuronal structure and function. Neural Dev. 2010;5:7.","journal-title":"Neural Dev"},{"issue":"1","key":"1930_CR164","doi-asserted-by":"publisher","first-page":"35","DOI":"10.4149\/endo_2014_01_35","volume":"48","author":"J Jurcovicova","year":"2014","unstructured":"Jurcovicova J. Glucose transport in brain - effect of inflammation. Endocr Regul. 2014;48(1):35\u201348.","journal-title":"Endocr Regul"},{"issue":"3","key":"1930_CR165","doi-asserted-by":"publisher","first-page":"76","DOI":"10.4331\/wjbc.v11.i3.76","volume":"11","author":"T Wang","year":"2020","unstructured":"Wang T, Wang J, Hu X, Huang XJ, Chen GX. Current Understanding of glucose transporter 4 expression and functional mechanisms. World J Biol Chem. 2020;11(3):76\u201398.","journal-title":"World J Biol Chem"},{"issue":"9","key":"1930_CR166","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1007\/s00424-020-02441-x","volume":"472","author":"H Koepsell","year":"2020","unstructured":"Koepsell H. Glucose transporters in brain in health and disease. Pflugers Arch. 2020;472(9):1299\u2013343.","journal-title":"Pflugers Arch"},{"key":"1930_CR167","doi-asserted-by":"crossref","unstructured":"Faria-Pereira A, Morais VA, Synapses. The Brain\u2019s Energy-Demanding Sites. Int J Mol Sci. 2022;23(7).","DOI":"10.3390\/ijms23073627"},{"issue":"9","key":"1930_CR168","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1007\/s00424-020-02441-x","volume":"472","author":"H Koepsell","year":"2020","unstructured":"Koepsell H. Glucose transporters in brain in health and disease. Pfl\u00fcgers Archiv - Eur J Physiol. 2020;472(9):1299\u2013343.","journal-title":"Pfl\u00fcgers Archiv - Eur J Physiol"},{"issue":"10","key":"1930_CR169","doi-asserted-by":"publisher","first-page":"e0240907","DOI":"10.1371\/journal.pone.0240907","volume":"15","author":"OC d\u2019Almeida","year":"2020","unstructured":"d\u2019Almeida OC, Violante IR, Quendera B, Moreno C, Gomes L, Castelo-Branco M. The neurometabolic profiles of GABA and glutamate as revealed by proton magnetic resonance spectroscopy in type 1 and type 2 diabetes. PLoS ONE. 2020;15(10):e0240907.","journal-title":"PLoS ONE"},{"key":"1930_CR170","doi-asserted-by":"crossref","unstructured":"Li HL, van Rossum MC. Energy efficient synaptic plasticity. Elife. 2020;9.","DOI":"10.7554\/eLife.50804"},{"key":"1930_CR171","doi-asserted-by":"crossref","unstructured":"Nguyen TT, Ta QTH, Nguyen TKO, Nguyen TTD, Giau VV. Type 3 Diabetes and Its Role Implications in Alzheimer\u2019s Disease. Int J Mol Sci. 2020;21(9).","DOI":"10.3390\/ijms21093165"},{"key":"1930_CR172","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.jns.2017.11.031","volume":"388","author":"AZ Sherzai","year":"2018","unstructured":"Sherzai AZ, Shaheen M, Yu JJ, Talbot K, Sherzai D. Insulin resistance and cognitive test performance in elderly adults: National health and nutrition examination survey (NHANES). J Neurol Sci. 2018;388:97\u2013102.","journal-title":"J Neurol Sci"},{"issue":"3","key":"1930_CR173","doi-asserted-by":"publisher","first-page":"e149","DOI":"10.1038\/emm.2015.3","volume":"47","author":"B Kim","year":"2015","unstructured":"Kim B, Feldman EL. Insulin resistance as a key link for the increased risk of cognitive impairment in the metabolic syndrome. Exp Mol Med. 2015;47(3):e149.","journal-title":"Exp Mol Med"},{"key":"1930_CR174","doi-asserted-by":"crossref","unstructured":"Potenza MA, Sgarra L, Desantis V, Nacci C, Montagnani M. Diabetes and Alzheimer\u2019s Disease: Might Mitochondrial Dysfunction Help Deciphering the Common Path? Antioxid (Basel). 2021;10(8).","DOI":"10.3390\/antiox10081257"},{"key":"1930_CR175","doi-asserted-by":"publisher","first-page":"964075","DOI":"10.3389\/fcell.2022.964075","volume":"10","author":"H Zhang","year":"2022","unstructured":"Zhang H, Jiang X, Ma L, Wei W, Li Z, Chang S, et al. Role of A\u03b2 in Alzheimer\u2019s-related synaptic dysfunction. Front Cell Dev Biol. 2022;10:964075.","journal-title":"Front Cell Dev Biol"},{"key":"1930_CR176","doi-asserted-by":"publisher","first-page":"931473","DOI":"10.3389\/fimmu.2022.931473","volume":"13","author":"H Dong","year":"2022","unstructured":"Dong H, Zhang Y, Huang Y, Deng H. Pathophysiology of RAGE in inflammatory diseases. Front Immunol. 2022;13:931473.","journal-title":"Front Immunol"},{"issue":"1","key":"1930_CR177","doi-asserted-by":"publisher","first-page":"240","DOI":"10.2741\/s265","volume":"4","author":"SS Yan","year":"2012","unstructured":"Yan SS, Chen D, Yan S, Guo L, Du H, Chen JX. RAGE is a key cellular target for Abeta-induced perturbation in Alzheimer\u2019s disease. Front Biosci (Schol Ed). 2012;4(1):240\u201350.","journal-title":"Front Biosci (Schol Ed)"},{"issue":"1","key":"1930_CR178","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s40035-020-00195-1","volume":"9","author":"Y Cheng","year":"2020","unstructured":"Cheng Y, Tian DY, Wang YJ. Peripheral clearance of brain-derived A\u03b2 in Alzheimer\u2019s disease: pathophysiology and therapeutic perspectives. Transl Neurodegener. 2020;9(1):16.","journal-title":"Transl Neurodegener"},{"issue":"1","key":"1930_CR179","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s40035-020-00195-1","volume":"9","author":"Y Cheng","year":"2020","unstructured":"Cheng Y, Tian D-Y, Wang Y-J. Peripheral clearance of brain-derived A\u03b2 in Alzheimer\u2019s disease: pathophysiology and therapeutic perspectives. Translational Neurodegeneration. 2020;9(1):16.","journal-title":"Translational Neurodegeneration"},{"key":"1930_CR180","doi-asserted-by":"publisher","first-page":"105417","DOI":"10.1016\/j.neuint.2022.105417","volume":"160","author":"PX Zz","year":"2022","unstructured":"Zz PX, Gg L, Lp J, Cm W, Yl B. The role of LRP1 in A\u03b2 efflux transport across the blood-brain barrier and cognitive dysfunction in diabetes mellitus. Neurochem Int. 2022;160:105417.","journal-title":"Neurochem Int"},{"key":"1930_CR181","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1146\/annurev-immunol-051116-052358","volume":"35","author":"M Colonna","year":"2017","unstructured":"Colonna M, Butovsky O. Microglia function in the central nervous system during health and neurodegeneration. Annu Rev Immunol. 2017;35:441\u201368.","journal-title":"Annu Rev Immunol"},{"key":"1930_CR182","doi-asserted-by":"publisher","first-page":"856376","DOI":"10.3389\/fimmu.2022.856376","volume":"13","author":"Y Cai","year":"2022","unstructured":"Cai Y, Liu J, Wang B, Sun M, Yang H. Microglia in the neuroinflammatory pathogenesis of Alzheimer\u2019s disease and related therapeutic targets. Front Immunol. 2022;13:856376.","journal-title":"Front Immunol"},{"issue":"1","key":"1930_CR183","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s11658-023-00462-9","volume":"28","author":"Y Chen","year":"2023","unstructured":"Chen Y, Ye X, Escames G, Lei W, Zhang X, Li M, et al. The NLRP3 inflammasome: contributions to inflammation-related diseases. Cell Mol Biol Lett. 2023;28(1):51.","journal-title":"Cell Mol Biol Lett"},{"issue":"12","key":"1930_CR184","doi-asserted-by":"publisher","first-page":"e84269","DOI":"10.1371\/journal.pone.0084269","volume":"8","author":"C van Kralingen","year":"2013","unstructured":"van Kralingen C, Kho DT, Costa J, Angel CE, Graham ES. Exposure to inflammatory cytokines IL-1\u03b2 and TNF\u03b1 induces compromise and death of astrocytes; implications for chronic neuroinflammation. PLoS ONE. 2013;8(12):e84269.","journal-title":"PLoS ONE"},{"issue":"4","key":"1930_CR185","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1210\/endrev\/bnad005","volume":"44","author":"V Vella","year":"2023","unstructured":"Vella V, Lappano R, Bonavita E, Maggiolini M, Clarke RB, Belfiore A, et al. Insulin\/IGF axis and the receptor for advanced glycation end products: role in Meta-inflammation and potential in cancer therapy. Endocr Rev. 2023;44(4):693\u2013723.","journal-title":"Endocr Rev"},{"key":"1930_CR186","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.neuropharm.2017.12.026","volume":"131","author":"H Wang","year":"2018","unstructured":"Wang H, Chen F, Du Y-F, Long Y, Reed MN, Hu M, et al. Targeted Inhibition of RAGE reduces amyloid-\u03b2 influx across the blood-brain barrier and improves cognitive deficits in db\/db mice. Neuropharmacology. 2018;131:143\u201353.","journal-title":"Neuropharmacology"},{"issue":"1","key":"1930_CR187","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/s41392-023-01588-0","volume":"8","author":"C Gao","year":"2023","unstructured":"Gao C, Jiang J, Tan Y, Chen S. Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets. Signal Transduct Target Therapy. 2023;8(1):359.","journal-title":"Signal Transduct Target Therapy"},{"key":"1930_CR188","doi-asserted-by":"crossref","unstructured":"Yu H, Xiong M, Zhang Z. The role of glycogen synthase kinase 3 beta in neurodegenerative diseases. Front Mol Neurosci. 2023;16.","DOI":"10.3389\/fnmol.2023.1209703"},{"key":"1930_CR189","doi-asserted-by":"crossref","unstructured":"Rawat P, Sehar U, Bisht J, Selman A, Culberson J, Reddy PH. Phosphorylated Tau in Alzheimer\u2019s disease and other tauopathies. Int J Mol Sci. 2022;23(21):12841.","DOI":"10.3390\/ijms232112841"},{"issue":"9","key":"1930_CR190","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1139\/apnm-2020-0005","volume":"45","author":"JF Halling","year":"2020","unstructured":"Halling JF, Pilegaard H. PGC-1\u03b1-mediated regulation of mitochondrial function and physiological implications. Appl Physiol Nutr Metab. 2020;45(9):927\u201336.","journal-title":"Appl Physiol Nutr Metab"},{"issue":"1","key":"1930_CR191","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/s41392-024-01756-w","volume":"9","author":"L Qian","year":"2024","unstructured":"Qian L, Zhu Y, Deng C, Liang Z, Chen J, Chen Y, et al. Peroxisome proliferator-activated receptor gamma coactivator-1 (PGC-1) family in physiological and pathophysiological process and diseases. Signal Transduct Target Therapy. 2024;9(1):50.","journal-title":"Signal Transduct Target Therapy"},{"key":"1930_CR192","doi-asserted-by":"crossref","unstructured":"Abu Shelbayeh O, Arroum T, Morris S, Busch KB. PGC-1\u03b1 is a master regulator of mitochondrial lifecycle and ROS stress response. Antioxid. 2023;12(5).","DOI":"10.3390\/antiox12051075"},{"key":"1930_CR193","doi-asserted-by":"publisher","first-page":"871357","DOI":"10.3389\/fcell.2022.871357","volume":"10","author":"L Chen","year":"2022","unstructured":"Chen L, Qin Y, Liu B, Gao M, Li A, Li X, et al. PGC-1\u03b1-Mediated mitochondrial quality control: molecular mechanisms and implications for heart failure. Front Cell Dev Biol. 2022;10:871357.","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"1930_CR194","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/cns.12655","volume":"23","author":"M Golpich","year":"2017","unstructured":"Golpich M, Amini E, Mohamed Z, Azman Ali R, Mohamed Ibrahim N, Ahmadiani A. Mitochondrial dysfunction and biogenesis in neurodegenerative diseases: pathogenesis and treatment. CNS Neurosci Ther. 2017;23(1):5\u201322.","journal-title":"CNS Neurosci Ther"},{"key":"1930_CR195","doi-asserted-by":"crossref","unstructured":"Yang W, Lyu Y, Xiang R, Yang J. Long noncoding RNAs in the pathogenesis of insulin resistance. Int J Mol Sci. 2022;23(24):16054.","DOI":"10.3390\/ijms232416054"},{"issue":"4","key":"1930_CR196","doi-asserted-by":"publisher","first-page":"548","DOI":"10.7150\/ijms.30097","volume":"16","author":"LE Abdulle","year":"2019","unstructured":"Abdulle LE, Hao JL, Pant OP, Liu XF, Zhou DD, Gao Y, et al. MALAT1 as a diagnostic and therapeutic target in Diabetes-Related complications: A promising Long-Noncoding RNA. Int J Med Sci. 2019;16(4):548\u201355.","journal-title":"Int J Med Sci"},{"issue":"5","key":"1930_CR197","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1093\/cvr\/cvx013","volume":"113","author":"S Greco","year":"2017","unstructured":"Greco S, Zaccagnini G, Fuschi P, Voellenkle C, Carrara M, Sadeghi I, et al. Increased BACE1-AS long noncoding RNA and \u03b2-amyloid levels in heart failure. Cardiovascular Res. 2017;113(5):453\u201363.","journal-title":"Cardiovascular Res"},{"issue":"12","key":"1930_CR198","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.4103\/1673-5374.284990","volume":"15","author":"K Doxtater","year":"2020","unstructured":"Doxtater K, Tripathi MK, Khan MM. Recent advances on the role of long non-coding RNAs in Alzheimer\u2019s disease. Neural Regen Res. 2020;15(12):2253\u20134.","journal-title":"Neural Regen Res"},{"issue":"3","key":"1930_CR199","doi-asserted-by":"publisher","first-page":"fcaf213","DOI":"10.1093\/braincomms\/fcaf213","volume":"7","author":"Q Mart\u00edn-Saladich","year":"2025","unstructured":"Mart\u00edn-Saladich Q, Pareto D, Sim\u00f3 R, Ciudin A, Aparicio C, Hammawa K, et al. Brain [(18)F]FDG uptake patterns in type 2 diabetes: new phenotypes relating to biomarkers of cognitive impairment. Brain Commun. 2025;7(3):fcaf213.","journal-title":"Brain Commun"},{"key":"1930_CR200","doi-asserted-by":"crossref","unstructured":"Bl\u00e1zquez E, Hurtado-Carneiro V, LeBaut-Ayuso Y, Vel\u00e1zquez E, Garc\u00eda-Garc\u00eda L, G\u00f3mez-Oliver F et al. Significance of brain glucose hypometabolism, altered insulin signal transduction, and insulin resistance in several neurological diseases. Front Endocrinol. 2022;13:873301.","DOI":"10.3389\/fendo.2022.873301"},{"key":"1930_CR201","doi-asserted-by":"publisher","first-page":"e20240191","DOI":"10.1590\/1980-5764-dn-2024-0191","volume":"19","author":"LJ de Oliveira Andrade","year":"2025","unstructured":"de Oliveira Andrade LJ, Matos G, Matos de Oliveira L. Intranasal insulin in Alzheimer disease (diabetes in situ?): a systematic review and meta-analysis. Dement Neuropsychol. 2025;19:e20240191.","journal-title":"Dement Neuropsychol"},{"issue":"1","key":"1930_CR202","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s40035-024-00431-y","volume":"13","author":"J Mei","year":"2024","unstructured":"Mei J, Li Y, Niu L, Liang R, Tang M, Cai Q, et al. SGLT2 inhibitors: a novel therapy for cognitive impairment via multifaceted effects on the nervous system. Translational Neurodegeneration. 2024;13(1):41.","journal-title":"Translational Neurodegeneration"},{"issue":"1","key":"1930_CR203","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s13098-024-01325-9","volume":"16","author":"R Zhang","year":"2024","unstructured":"Zhang R, Xie Q, Lu X, Fan R, Tong N. Research advances in the anti-inflammatory effects of SGLT inhibitors in type 2 diabetes mellitus. Diabetol Metab Syndr. 2024;16(1):99.","journal-title":"Diabetol Metab Syndr"},{"key":"1930_CR204","doi-asserted-by":"crossref","unstructured":"Wici\u0144ski M, W\u00f3dkiewicz E, G\u00f3rski K, Walczak M, Malinowski B. Perspective of SGLT2 Inhibition in treatment of conditions connected to neuronal loss: focus on Alzheimer\u2019s disease and Ischemia-Related brain injury. Pharmaceuticals. 2020;13(11).","DOI":"10.3390\/ph13110379"},{"issue":"1","key":"1930_CR205","doi-asserted-by":"publisher","first-page":"e52","DOI":"10.1002\/brx2.52","volume":"2","author":"L Hu","year":"2024","unstructured":"Hu L, Wang W, Chen X, Bai G, Ma L, Yang X, et al. Prospects of antidiabetic drugs in the treatment of neurodegenerative disease. Brain-X. 2024;2(1):e52.","journal-title":"Brain-X"},{"key":"1930_CR206","doi-asserted-by":"crossref","unstructured":"Quan Q, Qian Y, Li X, Li M. Pioglitazone reduces \u03b2 amyloid levels via Inhibition of PPAR\u03b3 phosphorylation in a neuronal model of Alzheimer\u2019s disease. Front Aging Neurosci. 2019;11.","DOI":"10.3389\/fnagi.2019.00178"},{"issue":"1","key":"1930_CR207","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s12974-021-02185-0","volume":"18","author":"L Zhang","year":"2021","unstructured":"Zhang L, Tang M, Xie X, Zhao Q, Hu N, He H, et al. Ginsenoside Rb1 induces a pro-neurogenic microglial phenotype via PPAR\u03b3 activation in male mice exposed to chronic mild stress. J Neuroinflamm. 2021;18(1):171.","journal-title":"J Neuroinflamm"},{"issue":"1","key":"1930_CR208","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1186\/s12974-016-0728-y","volume":"13","author":"Q Zhao","year":"2016","unstructured":"Zhao Q, Wu X, Yan S, Xie X, Fan Y, Zhang J, et al. The antidepressant-like effects of Pioglitazone in a chronic mild stress mouse model are associated with PPAR\u03b3-mediated alteration of microglial activation phenotypes. J Neuroinflamm. 2016;13(1):259.","journal-title":"J Neuroinflamm"},{"key":"1930_CR209","doi-asserted-by":"publisher","first-page":"178","DOI":"10.3389\/fnagi.2019.00178","volume":"11","author":"Q Quan","year":"2019","unstructured":"Quan Q, Qian Y, Li X, Li M. Pioglitazone reduces \u03b2 amyloid levels via Inhibition of PPAR\u03b3 phosphorylation in a neuronal model of Alzheimer\u2019s disease. Front Aging Neurosci. 2019;11:178.","journal-title":"Front Aging Neurosci"},{"issue":"2","key":"1930_CR210","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1177\/2042018815574229","volume":"6","author":"N Aghamohammadzadeh","year":"2015","unstructured":"Aghamohammadzadeh N, Niafar M, Dalir Abdolahinia E, Najafipour F, Mohamadzadeh Gharebaghi S, Adabi K, et al. The effect of Pioglitazone on weight, lipid profile and liver enzymes in type 2 diabetic patients. Ther Adv Endocrinol Metab. 2015;6(2):56\u201360.","journal-title":"Ther Adv Endocrinol Metab"},{"key":"1930_CR211","doi-asserted-by":"publisher","first-page":"101979","DOI":"10.1016\/j.arr.2023.101979","volume":"89","author":"J Nowell","year":"2023","unstructured":"Nowell J, Blunt E, Gupta D, Edison P. Antidiabetic agents as a novel treatment for Alzheimer\u2019s and parkinson\u2019s disease. Ageing Res Rev. 2023;89:101979.","journal-title":"Ageing Res Rev"},{"key":"1930_CR212","doi-asserted-by":"publisher","first-page":"1330797","DOI":"10.3389\/fphar.2024.1330797","volume":"15","author":"A Buczy\u0144ska","year":"2024","unstructured":"Buczy\u0144ska A, Sidorkiewicz I, Kr\u0119towski AJ, Adamska A. Examining the clinical relevance of Metformin as an antioxidant intervention. Front Pharmacol. 2024;15:1330797.","journal-title":"Front Pharmacol"},{"key":"1930_CR213","doi-asserted-by":"crossref","unstructured":"Pizcueta P, Vergara C, Emanuele M, Vilalta A, Rodr\u00edguez-Pascau L, Martinell M. Development of PPAR\u03b3 agonists for the treatment of neuroinflammatory and neurodegenerative diseases: Leriglitazone as a promising candidate. Int J Mol Sci. 2023;24(4).","DOI":"10.3390\/ijms24043201"}],"container-title":["Diabetology & Metabolic Syndrome"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-025-01930-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13098-025-01930-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-025-01930-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T18:55:37Z","timestamp":1757444137000},"score":1,"resource":{"primary":{"URL":"https:\/\/dmsjournal.biomedcentral.com\/articles\/10.1186\/s13098-025-01930-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,27]]},"references-count":213,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1930"],"URL":"https:\/\/doi.org\/10.1186\/s13098-025-01930-2","relation":{},"ISSN":["1758-5996"],"issn-type":[{"value":"1758-5996","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,27]]},"assertion":[{"value":"30 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"356"}}